BI Asset Management Fondsmaeglerselskab A S Increases Stake in Tenet Healthcare Corporation $THC

BI Asset Management Fondsmaeglerselskab A S raised its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 9.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 125,992 shares of the company’s stock after acquiring an additional 10,951 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Tenet Healthcare were worth $25,581,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in THC. AlphaQuest LLC boosted its position in shares of Tenet Healthcare by 230.8% in the 2nd quarter. AlphaQuest LLC now owns 1,763 shares of the company’s stock worth $310,000 after purchasing an additional 1,230 shares in the last quarter. WCM Investment Management LLC boosted its holdings in Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after acquiring an additional 362,083 shares in the last quarter. Winnow Wealth LLC bought a new position in shares of Tenet Healthcare during the third quarter valued at $1,129,000. Cerity Partners LLC boosted its stake in Tenet Healthcare by 10.4% in the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after purchasing an additional 11,395 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new stake in Tenet Healthcare during the 3rd quarter valued at about $1,648,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.81% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Morgan Stanley reiterated an “overweight” rating and set a $247.00 price target on shares of Tenet Healthcare in a report on Thursday, December 18th. Royal Bank Of Canada lifted their target price on Tenet Healthcare from $252.00 to $253.00 and gave the stock an “outperform” rating in a report on Tuesday. UBS Group reaffirmed a “buy” rating on shares of Tenet Healthcare in a research report on Tuesday. KeyCorp boosted their target price on Tenet Healthcare from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 31st. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and an average price target of $233.88.

Key Stories Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet announced it has regained ownership of Conifer in a transaction valued at about $1.9 billion, restoring full control of its revenue-cycle management business — a move that could boost margins, accelerate integration of Conifer’s technology and lift future earnings. Tenet regains ownership of Conifer in $1.9B deal
• Positive Sentiment: Analysts (Zacks) expect Tenet to again beat EPS estimates — citing its recent surprise history and the company’s combination of revenue growth and margin drivers — which supports near-term upside if results confirm the optimism. Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
• Neutral Sentiment: Industry review pieces on ambulatory surgery centers provide broader sector context for Tenet’s outpatient strategy but are unlikely to move the stock by themselves. ASCs in 2025: A Year in Review
• Negative Sentiment: Details about the Conifer/CommonSpirit buyback show a larger cash/consideration footprint (~$2.65B reported by HealthLeaders), raising questions about how the deal is financed and the potential impact on leverage and liquidity — a concern given Tenet’s existing debt-to-equity and capital intensity. This financing uncertainty likely pressured the stock despite the strategic upside. Tenet Healthcare details $2.65B in Conifer-CommonSpirit buy back

Tenet Healthcare Stock Down 1.1%

THC opened at $190.80 on Thursday. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $222.82. The firm’s 50 day simple moving average is $199.33 and its two-hundred day simple moving average is $192.37. The company has a current ratio of 1.71, a quick ratio of 1.64 and a debt-to-equity ratio of 2.27. The company has a market capitalization of $16.77 billion, a PE ratio of 13.08, a PEG ratio of 0.82 and a beta of 1.44.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.